A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepared. Except for six compounds exhibiting Ki > 100 nM, all the quinolone-3-carboxamides 2 proved to be high affinity CB2 ligands, with Ki values ranging from 73.2 to 0.7 nM and selectivity [SI = Ki(CB1)/Ki(CB2)] varying from >14285 to 1.9, with only 2ah exhibiting a reverse selectivity (SI < 1). In the formalin test of peripheral acute and inflammatory pain in mice, 2ae showed analgesic activity that was antagonized by a selective CB2 antagonist. By contrast, 2e was inactive per se and antagonized the effect of a selective CB2 agonist. Finally, 2g and 2p exhibited CB2 inverse agonist-like behavior in this in vivo...
Tetrahydrocannabinol and other mixed cannabinoid (CB) receptors CB(1)/CB(2) receptor agonists are we...
In recent years, cannabinoid type 2 receptors (CB2R) have emerged as promising therapeutic targets i...
In our search for new cannabinoid receptor modulators, we describe herein the design and synthesis o...
A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicy...
A set of quinolone-3-carboxamides 11 bearing at position 5, 6, 7, or 8 diverse substituents, such as...
A set of quinolone-3-carboxamides 11 bearing at position 5, 6, 7, or 8 diverse substituents, such as...
Within our studies on structureeactivity relationships of 4-quinolone-3-carboxamides as cannabinoid ...
Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series ...
Recent data indicated that the CB,, cannabinoid receptor constitutes an attractive drug target due t...
Targeting type-2 cannabinoid receptor (CB2) is considered a feasible strategy to develop new drugs f...
4-Quinolone-3-carboxamide derivatives have long been recognized as potent and selective cannabinoid ...
4-Quinolone-3-carboxamide derivatives have long been recognized as potent and selective cannabinoid ...
There is growing interest in using cannabinoid receptor 2 (CB2) agonists for the treatment of neurop...
CB2 receptor selective ligands are becoming increasingly attractive drugs due to the potential role ...
Tetrahydrocannabinol and other mixed cannabinoid (CB) receptors CB(1)/CB(2) receptor agonists are we...
In recent years, cannabinoid type 2 receptors (CB2R) have emerged as promising therapeutic targets i...
In our search for new cannabinoid receptor modulators, we describe herein the design and synthesis o...
A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicy...
A set of quinolone-3-carboxamides 11 bearing at position 5, 6, 7, or 8 diverse substituents, such as...
A set of quinolone-3-carboxamides 11 bearing at position 5, 6, 7, or 8 diverse substituents, such as...
Within our studies on structureeactivity relationships of 4-quinolone-3-carboxamides as cannabinoid ...
Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series ...
Recent data indicated that the CB,, cannabinoid receptor constitutes an attractive drug target due t...
Targeting type-2 cannabinoid receptor (CB2) is considered a feasible strategy to develop new drugs f...
4-Quinolone-3-carboxamide derivatives have long been recognized as potent and selective cannabinoid ...
4-Quinolone-3-carboxamide derivatives have long been recognized as potent and selective cannabinoid ...
There is growing interest in using cannabinoid receptor 2 (CB2) agonists for the treatment of neurop...
CB2 receptor selective ligands are becoming increasingly attractive drugs due to the potential role ...
Tetrahydrocannabinol and other mixed cannabinoid (CB) receptors CB(1)/CB(2) receptor agonists are we...
In recent years, cannabinoid type 2 receptors (CB2R) have emerged as promising therapeutic targets i...
In our search for new cannabinoid receptor modulators, we describe herein the design and synthesis o...